本システムでは、JavaScriptを利用しています。JavaScriptを有効に設定してからご利用ください。
Skip to main content
Contact Us
Accessibility
LANGUAGE
JP
EN
HOME
About ASKA Pharmaceutical Holdings
Top Message
Corporate Philosophy
Company Overview
Charter of Corporate Behavior
Board Members and Corporate Officers
Company Information
Group Companies
Business Activities
Corporate Message
Digital Transformation
ASKA Pharmaceutical Holdings in Numbers
For Our Shareholders and Investors
Top Message
IR News
IR Library
IR Calendar
Management Strategies and Policies
Governance
Financial Highlights
ASKA Pharmaceutical Holdings at a glance
IR Related Information
Stock and Shareholder Information
Sustainability
Our Sustainability
Environmental
Social
Governance (Related Link)
ESG Chart and ESG Data Book
External Evaluation
Initiatives and Member Organizations
Third-party Opinion
Sustainability News
Various Contrasting Tables
Policies (Related Link)
Integrated Report (Related Link)
Press Releases
Contact Us
Privacy Policy
Basic Policy on the Proper Handling of Specific Personal Information, etc.
Terms of Use
Web Accessibility Policy
SNS Community Guidelines
Official website and SNS
Sitemap
Search Results
About ASKA Pharmaceutical Holdings
Company Overview
Group Companies
Top Message
Corporate Philosophy
Charter of Corporate Behavior
Board Members and Corporate Officers
Company Information
Business Activities
Corporate Message
Digital Transformation
ASKA Pharmaceutical Holdings in Numbers
For Our Shareholders and Investors
Top Message
Management Strategies and Policies
IR News
IR Library
IR Calendar
Governance
Financial Highlights
ASKA Pharmaceutical Holdings at a glance
IR Related Information
Stock & Shareholder Information
Sustainability
Integrated Report (Related links)
Our Basic Policy for Sustainability
Various Contrasting Tables
Our Sustainability
Top Commitment
Our Basic Policy for Sustainability
Materiality
Value Creation Process
Capital and Strengths
Initiatives for Sustainability and SDGs
Importance of Female Healthcare and Social Issues
Disclosures based on TCFD recommendations
Disclosures based on TNFD recommendations
Environmental
Governance (Related links)
External Evaluation
Third-party Opinion
Various Contrasting Tables
Integrated Report (Related links)
Social
ESG Chart and ESG Data Book
Initiatives and Member Organizations
Sustainability News
Policies (Related links)
HOME
>
HOME
>
Sustainability
>
Sustainability News
Sustainability News
PRINT
FY2025
FY2024
FY2023
FY2022
FY2021
FY2025
January 9, 2026
ASKA Pharmaceutical Announces the Conclusion of Its 20th Anniversary Social Contribution Project “Wings of Women” — A Total of 1,373 Participants and ¥9.42 Million in Support Raised [PDF] (Japanese version only)
January 7, 2026
“Mint⁺,” a Women’s Health Lab Operated by Aska Pharmaceutical, Launches New “Exercise” Video Content on Its Website and Opens the “Mint⁺ YouTube Channel” [PDF] (Japanese version only)
December 19, 2025
ASKA Pharmaceutical Announces Ongoing Crowdfunding for Its 20th Anniversary Social Contribution Project “Wings of Women” [PDF] (Japanese version only)
December 17, 2025
ASKA Achieves Score of B in Climate Change B- in Water Security and C in Forests at CDP2025[PDF](Japanese version only)
December 15, 2025
Integrated Report 2025 (ASKA HD REPORT 2025) has been disclosed
November 14, 2025
ASKA Pharmaceutical Announces Achievement of Charity Walk Target and Launch of Crowdfunding for Its 20th Anniversary Social Contribution Project “Wings of Women” [PDF]
November 6, 2025
ASKA Pharmaceutical Presents Research Findings on Menstrual-Related Symptoms at the 40th Annual Meeting of the Japan Society of Obstetrics and Gynecology for Women’s Health [PDF] (Japanese version only)
October 24, 2025
“Mint⁺ Helpful Column” Adds Vol.12: “How Do You Feel About Visiting a Gynecologist? We’ve Compiled Everyone’s Opinions”
October 1, 2025
[Mint⁺] Apology and Correction Regarding the “Survey on Self-Care for Menstrual-Related Symptoms Among Working Women” [PDF] (Japanese version only)
October 1, 2025
ASKA Pharmaceutical Launches Social Contribution Project “Wings of Women” as Part of Its 20th Anniversary Initiatives Starting October 1 [PDF] (Japanese version only)
October 1, 2025
ASKA Pharmaceutical Announces 20th Anniversary Initiatives[PDF]
October 1, 2025
ASKA Pharmaceutical launches the social contribution project “Wings of Women” as part of its 20th Anniversary Commemorative Program [PDF](Japanese version only)
October 1, 2025
[Mint⁺] Notice of Apology and Correction regarding the “Survey on Self-Care for Menstrual-Related Symptoms among Working Women” [PDF](Japanese version only)
September 30, 2025
Integrated Report “ASKA HD REPORT 2025” Published (English version in November)
September 30, 2025
[Mint⁺ FemKnowledge] Joint launch by Asahi Advertising and ASKA Pharmaceutical of the “Menopause Seminar” educational program using a “card game” and “video” [PDF](Japanese version only)
September 29, 2025
[Mint⁺teens] Added to Pick-up Contents: “Future Readiness You Can Start Now / Practicing Preconception Care!(Japanese version only)”
September 29, 2025
[Mint⁺teens] Added to Pick-up Contents: “Future Readiness to Start Being Mindful of Now / Preconception Care”(Japanese version only)
September 19, 2025
[Mint⁺] Published: “Survey on Self-Care for Menstrual-Related Symptoms among Working Women” [PDF](Japanese version only)
September 12, 2025
ASKA Selected as Excellent Company in “Gomez ESG Web Awards 2025”
August 29, 2025
ESG Data Book 2025 is now available
August 20, 2025
ASKA Becomes DX-Certified Operator Recognized by METI[PDF]
Jun 27, 2025
“About us” added to Mint
+
TOP page, a health lab for women (Japanese version only)
May 29, 2025
Mint
+
Hug's “Column for Newborns and Infants” has been updated with “Illnesses and Problems in Newborns and Infants.”(Japanese version only)
May 19, 2025
Announcement of a survey report on “Support Services for Working Women”[PDF](Japanese version only)
FY2024
March 24, 2025
ASKA Selected under the FY2024 “Next Nadeshiko Companies Supporting Dual-career and Co-parenting”[PDF]
March 18, 2025
Added “Baby Growth and Parenting Tips” to Mint
+
Hug's “Column for Newborns and Infants." (Japanese version only)
March 10, 2025
ASKA Pharmaceutical Holdings Group Recognized as White 500 Enterprise for Seventh Consecutive Year
February 20, 2025
ASKA Pharmaceutical Co-sponsors the 2025 Marunouchi Career Academy Special Seminar (Japanese version only)
February 10, 2025
ASKA Achieves Score of B in Climate Change, B- in Water Security at CDP2024
December 17, 2024
Received the Excellence Award in the Business Category of the “2024 Tokyo Women's Advancement Promotion Award” (Japanese version only)
November 5, 2024
Integrated Report 2024 (ASKA HD REPORT 2024) has been disclosed
September 24, 2024
ASKA Pharmaceutical changes the packaging of its pharmaceutical products in consideration of the environment. (Japanese version only)
August 9, 2024
ESG Data Book 2024 is now available
June 17, 2024
ASKA Pharmaceutical Obtains "FIT Non-Fossil Certificate/Renewable Energy Certificate" for its Head Office Building (Japanese version only)
June 14, 2024
ASKA Pharmaceutical Begins Receiving Solar-Powered Electricity from On-Site PPA (Japanese version only)
May 20, 2024
May 25th is World Thyroid Day (Japanese version only)
April 23, 2024
ASKA Pharmaceutical Exhibits at the 4th HEALTH MANAGEMENT EXPO SPRING (Japanese version only)
April 1, 2024
ASKA Pharmaceutical Initiates “Work Support Grant” Program and Cancer Insurance Program for All Regular Employees
FY2023
February 22, 2024
ESG Data Book has been updated
October 31, 2023
Integrated Report 2023 (ASKA HD REPORT 2023) has been uploaded
July 10, 2023
ESG Data Book has been updated
April 21, 2023
ASKA Pharmaceutical Holdings Installs CO₂-Free Electricity and Solar Power Generation Facilities
April 3, 2023
Message from Board Member in Charge of Sustainability has been posted
FY2022
March 30, 2023
The web page "Decarbonization Initiatives" has been disclosed
March 8, 2023
ASKA Pharmaceutical Holdings Recognized as a White 500 enterprise for the Fifth Consecutive Year
February 13, 2023
ESG Data Book has been updated
October 27, 2022
Integrated Report 2022 (ASKA HD REPORT 2022) has been uploaded
October 14, 2022
ESG Data Book has been updated
June 6, 2022
The web page "Disclosures based on TCFD recommendations" has been disclosed
FY2021
February 14 2022
Signing the United Nations Global CompactFinancial Results Presentation Material for FY2021
December 27, 2021
The web pages "Materiality" and "ESG Data Book" have been disclosed
April 1, 2021
The website of ASKA Pharmaceutical Holdings has been opened
Please download the free
Adobe Acrobat Reader DC
to view it.
About ASKA Pharmaceutical Holdings
Top Message
Corporate Philosophy
Company Overview
Charter of Corporate Behavior
Board Members and Corporate Officers
Company Information
Company Information
Organization Chart
Corporate History
Access Map
Policies
Video Library
Media Library
Group Companies
Business Activities
Corporate Message
Digital Transformation
ASKA Pharmaceutical Holdings in Numbers
For Our Shareholders and Investors
Top Message
IR News
IR Library
IR Library
Financial Results and IR Events
Annual Securities Report
Integrated Report
Fact Sheet
Corporate Governance Report (Japanese version only, Related links)
Internal Control Report (Japanese version only, Related links)
Stock and Shareholder Information (Related links)
IR Calendar
Management Strategies and Policies
Management Strategies and Policies
Medium-Term Management Plan
Pipeline and Intellectual Property
Business Risks
Disclosure Policy
IR Basic Policy
Disclaimer
Governance
Governance
Basic Principles / Corporate Governance Structure
Corporate Governance Basic Policy
Corporate Governance Report (Japanese version only)
Board Members
Compliance / Risk Management
Internal Control System
Internal Control Report (Japanese version only)
Dialogue with Shareholders
Message from Outside Directors
Financial Highlights
Financial Highlights
Performance Review
Performance Highlights
Financial Conditions
Financial Statements
Consolidated Balance Sheets
Consolidated Statements of Income
Consolidated Statements of Cash Flows
Earnings Forecast
ASKA Pharmaceutical Holdings at a glance
ASKA Pharmaceutical Holdings at a glance
Point1 About ASKA - Understanding & History -
Point2 About ASKA - Our Strengths -
Point3 Highly Specialized Product Lineup
Point4 Continuously Evolving R&D
Point5 Stable Shareholder Returns
Frequently Asked Questions
Business Model
ASKA's Management Strategy
Medicine & Body Glossary
IR seminar for Individual Investors
IR Related Information
IR Related Information
IR E-mail Newsletter Service
IR Site Map
Recommended Route to Access Our IR Website
How to Use the IR Site
IR Inquiries
External Evaluation (IR)
Stock and Shareholder Information
Stock and Shareholder Information
Stock Summary Information
Shareholder Information
Shareholders' Meeting
Stock Price Information
Shareholder Return
Stock Procedures (Japanese version only)
Articles of Incorporation and Stock Handling Regulations
Analyst Coverage
Corporate Bonds and Ratings Information
Shareholder Newsletters (Japanese version only)
Privacy Policy (Shareholders)
Sustainability
Our Sustainability
Our Sustainability
Top Commitment
Our Basic Policy for Sustainability
Materiality
Value Creation Process
Capital and Strengths
Initiatives for Sustainability and SDGs
Importance of Female Healthcare and Social Issues
Disclosures based on TCFD recommendations
Disclosures based on TNFD recommendations
Environmental
Environmental
Environmental Management
Disclosures Based on TCFD Recommendations
Disclosures based on TNFD recommendations
Decarbonization Initiatives
Initiatives for Water Resource
Initiatives for Recycle-Oriented Society and Biodiversity
Social
Social
Stakeholder Engagement
Respect for Human Rights
Human capital/Labour Practices
Diversity & Inclusion
Initiatives to Promote the Advancement of Women
Health Management Initiatives
Ethics and Compliance
Supply Chain
Customer Health and Safety
Social Contribution Activities（Community Involvement and Development）
Multi-Stakeholder Policy
Governance (Related Link)
ESG Chart and ESG Data Book
External Evaluation
Initiatives and Member Organizations
Third-party Opinion
Sustainability News
Various Contrasting Tables
Policies (Related Link)
Integrated Report (Related Link)
Press Releases
Contact Us
Privacy Policy
Basic Policy on the Proper Handling of Specific Personal Information, etc.
Terms of Use
Web Accessibility Policy
SNS Community Guidelines
Official website and SNS
Sitemap
Search Results
TOP